Aprima Medical Software, Inc

SI Group Announces Ultranox™ 626 U.S. FDA Approval Extension
Chemicals & Gases

SI Group Announces Ultranox™ 626 U.S. FDA Approval Extension

Phosphite Antioxidant Now Has Broader Approval for Food-Contact Applications SCHENECTADY, NY – July 11, 2019 – SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, is pleased to announce that its phosphite antioxidant ULTRANOX™ 626 has been granted an extension of existing approvals by the U.S....

Read More »

All Topics